Results 111 to 120 of about 5,887 (203)
Patient navigation as a core component of global cancer care-A call to action from the Global Alliance for Cancer Patient Navigation. [PDF]
CancerAgrawal AK, McComb K, Thamm C, Bhoo-Pathy N, Graetz D, Morris B, Cazap E, Chin M, Dent J, Fitch MI, Goel NS, Ibraheem MH, Landgraf KM, L'hôte M, Peña N, Queiros C, Schmeler K, Sullivan CE, Yost A, Chan RJ, Global Alliance for Cancer Patient Navigation. +20 moreeuropepmc +1 more sourceCorrelates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine. [PDF]
NPJ VaccinesJanes H, Fong Y, Huang Y, Benkeser D, Kelly EJ, Hirsch I, Stanley AM, Villafana T, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Isaacs MB, Makhene M, Tong T, Robb ML, Corey L, Neuzil KM, Follmann D, Falsey AR, Sobieszczyk ME, Koup RA, Gilbert PB, AstraZeneca AZD1222 Clinical Study Group, Immune Assays Team, United States Government (USG)/CoVPN Biostatistics Team. +33 moreeuropepmc +1 more sourceFeasibility and acceptability of task sharing collection of HIV viral load dried blood spot samples with community lay cadres: A cross-sectional diagnostic validation study in Zimbabwe. [PDF]
PLOS Glob Public HealthPrust ML, Graves JC, Jokwiro J, Giyava CR, Apollo T, Simbi R, Mupanguri C, Govha E, Chipuka S, Juru A, Kallarakal A, Kawaza N, Tsai Y, Maparo T. +13 moreeuropepmc +1 more sourceCo-creation of community-based innovations to improve access to malaria treatment in conflict-affected regions of Cameroon. [PDF]
Malar JOmam LA, Tanue EA, Omam EN, Metuge A, Nganmou I, Epie C, Kebam G, Ako S, Bessem ME, Hawkings H, Maxwell K, Zoungrana Y, Berryman E, Jarman E, Noukeme BM. +14 moreeuropepmc +1 more sourceHybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. [PDF]
EClinicalMedicineGarrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi NM, Andriesen J, Takalani A, Fisher LH, Kee JJ, Magaret CA, Villaran M, Hural J, Andersen-Nissen E, Ferarri G, Miner MD, Le Roux B, Wilkinson E, Lessells R, de Oliveira T, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samandari T, Chirenje Z, Elyanu PJ, Makhema J, Kamuti E, Nuwagaba-Biribonwoha H, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delany-Moretlwe S, Diacon AH, Fry S, Gill KM, Ebrahim Hoosain ZA, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Kasaro M, Kassim P, Kayange N, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, McHarry K, Mitha E, Mngadi K, Mda P, Moloantoa T, Mutuluuza CK, Naicker N, Naicker V, Nana A, Nanvubya A, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Tayob MS, Vahed Y, Wabwire DO, McElrath MJ, Kublin JG, Bekker LG, Gilbert PB, Corey L, Gray GE, Huang Y, Kotze P, CoVPN 3008 Ubuntu Study Team. +80 moreeuropepmc +1 more source